Oct 08, 2024
Effect of different cadences on a cycle ergometer on blood pressure in people with hypertension: an empty systematic review of randomized controlled trials
- Alexey Antonov1,
- Alexander Miroshnikov1,
- Polina Rybakova1
- 1Russian university of sports "GTSOLIFK"
Protocol Citation: Alexey Antonov, Alexander Miroshnikov, Polina Rybakova 2024. Effect of different cadences on a cycle ergometer on blood pressure in people with hypertension: an empty systematic review of randomized controlled trials. protocols.io https://dx.doi.org/10.17504/protocols.io.ewov19p6ylr2/v1
Manuscript citation:
None
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: October 08, 2024
Last Modified: October 08, 2024
Protocol Integer ID: 109345
Keywords: cadence, pedal speed, bicycle ergometer, arterial hypertension
Disclaimer
There is no conflict of interest and no source of funding
Abstract
Current guidelines recommend exercise as part of primary and secondary prevention of CVD. However, little has been discussed about the effects of different cadences on a bicycle/exercise bike in the prevention and treatment of hypertension. Systematic responses directly related to exercise depend on the intensity, duration and frequency of exercise.
Based on the analysis of the problem situation, data from modern scientific periodicals and requests from sports physicians, clinicians and specialists in exercise therapy, the aim of the study was formulated.
The aim of the study is to systematically search for and summarize randomized controlled trials on the effect of different cadences on a bicycle ergometer on blood pressure in people with hypertension.
Attachments
Guidelines
The review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [Dickson]. The study protocol was written and registered before the search began and was not changed during or after the search, according to the Preferred Reporting Items for Systematic Review and Meta-Analyses Protocols (PRISMA-P) [Shamseer].
The literature search was carried out according to PRESS (Peer Review of Electronic Search Strategies) [McGowan].
Materials
Search Strategy
Sources of information and search strategies The literature search was carried out according to PRESS (Peer Review of Electronic Search Strategies) [McGowan] in the databases (without restrictions on the date and language of publication): PubMed, MedNar, Cochrane Library, Epistemonikos and Еlibrary, using the keywords presented in the section "Description".
To increase the breadth of coverage of the topic under consideration, a grey literature search was conducted in the SportRχiv database according to the checklist of Benzies et al. [Benzies]. The reference lists of the retrieved studies were then hand-searched to identify potentially eligible studies not covered by the electronic search. No publication date or language restrictions were imposed. To be included in the review, a study had to meet the following inclusion criteria based on the PICOS system [Amir-Behghadami]. P (Population) – people with hypertension over 18 years old; I (Intervention) – performance of exercise protocols (long-term and short-term) on a cycle ergometer with different HR; C (Comparison) – comparison with a control group or the beginning of the intervention; O (Outcomes) – change in BP; S (Study) – RCT. Studies were excluded if: (a) HR was not stated; (b) the intervention was mixed.
Study selection. Initially, two review authors (PD Rybakova and AG Antonov) independently and in parallel screened article titles, abstracts, and, where appropriate, full texts from database records according to the eligibility criteria. Duplicates and articles that did not meet the criteria were excluded from the search. Any discrepancies were resolved by consensus discussion, and any disagreements were resolved by another reviewer (AB Miroshnikov).
Study extraction. Following the search, two review authors (PD Rybakova and AG Antonov) independently and in parallel screened the full texts according to the inclusion criteria. Duplicates and articles that did not meet the criteria were removed. Whenever disagreements arose between the assessments of the two researchers, consensus was reached either by discussion or with the help of a third reviewer (AB Miroshnikov). Inter-rater (kappa) agreement ranged from 0.53 (weak) to 1.00 (almost perfect), as recommended by McHugh [McHugh].
Data synthesis. Meta-analysis was not performed due to empty review
Before start
On October 1, 2024, we conducted a pilot screening according to the inclusion/exclusion criteria. We found that there was very limited data and conducted a full search strategy before protocol registration. We did not find any studies according to the inclusion/exclusion criteria. For this reason, this systematic review is designated as "empty".
Protocol references
Al-Makki A, DiPette D, Whelton PK, Murad MH, Mustafa RA, Acharya S, Beheiry HM, Champagne B, Connell K, Cooney MT, Ezeigwe N, Gaziano TA, Gidio A, Lopez-Jaramillo P, Khan UI, Kumarapeli V, Moran AE, Silwimba MM, Rayner B, Sukonthasan A, Yu J, Saraffzadegan N, Reddy KS, Khan T. Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary. Hypertension. 2022 Jan;79(1):293-301. doi: 10.1161/HYPERTENSIONAHA.121.18192.
Hanssen, H., Boardman, H., Deiseroth, A., Moholdt, T., Simonenko, M., Kränkel, N., Niebauer, J., Tiberi, M., Abreu, A., Solberg, E.E., Pescatello, L., Brguljan, J., Coca, A., Leeson, P. Personalized exercise prescription in the prevention and treatment of arterial hypertension: a Consensus Document from the European Association of Preventive Cardiology (EAPC) and the ESC Council on Hypertension // Eur J Prev Cardiol. – 2022. – №29(1). – Р.205-215. – doi: 10.1093/eurjpc/zwaa141.
Channon KM. Exercise and cardiovascular health: New routes to reap more rewards. Cardiovasc. Res. 2020;116:56–58. doi: 10.1093/cvr/cvz264.
Green DJ, Dawson EA, Groenewoud HM, Jones H, Thijssen DH. Is flow-mediated dilation nitric oxide mediated?: A meta-analysis. Hypertension. 2014 Feb;63(2):376-82. doi: 10.1161/HYPERTENSIONAHA.113.02044.
Picard M, McEwen BS, Epel ES, Sandi C. An energetic view of stress: Focus on mitochondria. Front. Neuroendocrinol. 2018;49:72–85. doi: 10.1016/j.yfrne.2018.01.001.
Edwards JJ, Deenmamode AHP, Griffiths M, Arnold O, Cooper NJ, Wiles JD, O'Driscoll JM. Exercise training and resting blood pressure: a large-scale pairwise and network meta-analysis of randomised controlled trials. Br J Sports Med. 2023 Oct;57(20):1317-1326. doi: 10.1136/bjsports-2022-106503.
Lin X, Zhang X, Guo J, Roberts CK, McKenzie S, Wu WC, Liu S, Song Y. Effects of Exercise Training on Cardiorespiratory Fitness and Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2015 Jun 26;4(7):e002014. doi: 10.1161/JAHA.115.002014.
McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement. J Clin Epidemiol. 2016 Jul;75:40-6. doi: 10.1016/j.jclinepi.2016.01.021.
Dickson, K. PRISMA 2020 updated guideline / K. Dickson, C. A. Yeung // Br Dent J. – 2022. –№ 232(11). – P. 760-761. DOI: 10.1038/s41415-022-4359-7.
Shamseer PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation / Shamseer L., Moher D., Clarke M. [et al.] // BMJ. – 2015. –№350. – P.g7647. DOI: 10.1136/bmj.g7647.
Benzies State-of-the-evidence reviews: advantages and challenges of including grey literature / K.M. Benzies, S. Premji, K.A. Hayden, K. Serrett // Worldviews Evid Based Nurs. – 2006. – №3(2). – P.55-61. DOI: 10.1111/j.1741-6787.2006.00051.x.
Amir-Behghadami, M. Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews / M. Amir-Behghadami, A. Janati // Emerg Med J. – 2020. – №37(6). – P.387. DOI: 10.1136/emermed-2020-209567.
McHugh, M. L. Interrater reliability: the kappa statistic / M. L. McHugh // Biochem Med (Zagreb). – 2012. – № 22(3). – P. 276-82.
Campbell Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline / Campbell M., McKenzie J., Sowden A. [et al.] // BMJ. – 2020. – №368. Р.l6890 DOI: 10.1136/bmj.l6890.